Cartesian Therapeutics, Inc. has announced the enrollment of the first participant in its Phase 3 AURORA trial for Descartes-08, its lead cell therapy candidate aimed at treating myasthenia gravis ...

A second Phase 3 trial, AERIFY-2, did not meet the same primary endpoint, although a benefit was seen earlier in the trial. In the trials, patients were randomized to receive itepekimab every two ...

Big Lots!, a leading discount retailer known for its treasure hunt shopping experience, closeouts, and unbeatable bargains, announces the fourth and final wave of its store reopenings, with 78 ...

Photo: Alan Bloodgood — DC Breeze Welcome to Better Box Score Metrics, our analytics column focused ... we’ve assessed to be the best individual game performances from Weeks 3-5. (We’re going 20 deep ...

Alumis Inc. has announced the successful completion of patient enrollment in its pivotal Phase 3 ONWARD clinical program for ESK-001, a treatment for moderate-to-severe plaque psoriasis ...

Consisting of unimproved land(the “Property”), together with all appurtenances and improvements thereto. This judicial sale will be conducted in accordance with the provisions of V.I. Code Ann. tit. 5 ...

Strand Therapeutics, a leader in next-generation mRNA-based therapeutics, today announced exciting preliminary Phase 1 clinical data for its lead investigational candidate, STX-001, in patients ...

An illustration of a magnifying glass. An illustration of a magnifying glass.

Copyright: © 2025 The Author(s). Published by Elsevier Ltd.

With retaliatory US tariffs looming, India is seeking to finalise the first phase of a multi-stage trade deal during Commerce Minister Piyush Goyal's Washington visit. While US acceptance of a phased ...